DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+10.81%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.53B
AUM Growth
+$2.53B
(+14%)
Cap. Flow
+$202M
Cap. Flow
% of AUM
7.99%
Top 10 Holdings %
Top 10 Hldgs %
33.99%
Holding
112
New
21
Increased
27
Reduced
21
Closed
14
Top Buys
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$88.1M |
| 2 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$35.8M |
| 3 |
DBVT
DBV Technologies
DBVT
|
$35.7M |
| 4 |
DaVita
DVA
|
$30.7M |
| 5 |
LCI
Lannett Company, Inc.
LCI
|
$29.3M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$87.6M |
| 2 |
McKesson
MCK
|
$52.1M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
$43.6M |
| 4 |
Viatris
VTRS
|
$27.5M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
$21.9M |
Sector Composition
| 1 | Healthcare | 78.98% |
| 2 | Financials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNK
1
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $130M | 5.12% | 5,766,000 +3,905,863 | +210% | +$88.1M |
|
|
2
Viatris
VTRS
$12.3B
| $106M | 4.17% | 2,503,611 -650,000 | -21% | -$27.5M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $92.6M | 3.64% | 6,341,894 -575,176 | -8% | -$8.4M |
|
4
DexCom
DXCM
$29.5B
| $88M | 3.47% | 1,534,211 +114,300 | +8% | +$6.56M |
|
5
Glaukos
GKOS
$5.5B
| $85.7M | 3.37% | 3,343,045 +816,013 | +32% | +$20.9M |
|
|
AVXS
6
DELISTED
AveXis, Inc. Common Stock
AVXS
| $83.6M | 3.29% | 755,798 -791,588 | -51% | -$87.6M |
|
7
AnaptysBio
ANAB
$569M
| $81.8M | 3.22% | 812,484 -11,854 | -1% | -$1.19M |
|
|
LCI
8
DELISTED
Lannett Company, Inc.
LCI
| $63M | 2.48% | 2,717,287 +1,264,028 | +87% | +$29.3M |
|
|
9
McKesson
MCK
$85.4B
| $61.6M | 2.42% | 394,801 -334,199 | -46% | -$52.1M |
|
10
Aclaris Therapeutics
ACRS
$209M
| $55.1M | 2.17% | 2,233,416 +655,489 | +42% | +$16.2M |
|
11
Editas Medicine
EDIT
$231M
| $52.5M | 2.07% | 1,709,400 | – | – |
|
|
DBVT
12
DBV Technologies
DBVT
$264M
| $51.8M | 2.04% | 2,105,180 +1,449,283 | +221% | +$35.7M |
|
|
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $51.7M | 2.04% | 1,522,566 +450,237 | +42% | +$15.3M |
|
14
Insulet
PODD
$23.9B
| $48.7M | 1.92% | 705,573 +208,573 | +42% | +$14.4M |
|
|
XENT
15
DELISTED
Intersect ENT, Inc
XENT
| $47.6M | 1.87% | 1,468,341 +258,341 | +21% | +$8.37M |
|
|
GWPH
16
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $44.8M | 1.76% | 339,180 -23,544 | -6% | -$3.11M |
|
17
Molina Healthcare
MOH
$9.8B
| $43.6M | 1.71% | 568,000 +310,000 | +120% | +$23.8M |
|
|
MYOK
18
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $42.1M | 1.66% | 1,000,680 -364,359 | -27% | -$15.3M |
|
|
BOLD
19
DELISTED
Audentes Therapeutics, Inc
BOLD
| $37.2M | 1.46% | 1,190,516 -334,894 | -22% | -$10.5M |
|
|
RVNC
20
DELISTED
Revance Therapeutics, Inc.
RVNC
| $35.8M | 1.41% | +1,000,000 | New | +$35.8M |
|
21
BioCryst Pharmaceuticals
BCRX
$1.74B
| $35.4M | 1.39% | 7,213,393 +2,237,942 | +45% | +$11M |
|
22
Select Medical
SEM
$1.61B
| $32.8M | 1.29% | 1,858,000 +663,391 | +56% | +$11.7M |
|
|
AVDL
23
Avadel Pharmaceuticals
AVDL
$1.43B
| $32.4M | 1.28% | 3,955,494 +300,000 | +8% | +$2.46M |
|
24
Ascendis Pharma
ASND
$11.8B
| $31.6M | 1.24% | 789,000 -61,000 | -7% | -$2.44M |
|
|
25
DaVita
DVA
$9.85B
| $30.7M | 1.21% | +425,000 | New | +$30.7M |
|